Neos Therapeutics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Neos Therapeutics (NEOS) Reports In-Line Q2 EPS
August 8, 2017 7:18 AM EDTNeos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($0.83), in-line with the analyst estimate of ($0.83). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.67 million.
For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.
... More